Found: 5
Select item for more details and to access through your institution.
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Incidence and Severity of Myelosuppression With Palbociclib After Palliative Bone Radiation in Advanced Breast Cancer: A Single Center Experience and Review of Literature.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 2, p. 389, doi. 10.1007/s10549-023-06910-6
- By:
- Publication type:
- Article
Initiation of exemestane in two warfarin-treated patients leading to elevation and variability of INR.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 2, p. 371, doi. 10.1177/1078155214568583
- By:
- Publication type:
- Article
Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article